Cargando…

Gene amplification‐driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A‐YTHDF2‐dependent in lung adenocarcinoma

BACKGROUND: Epigenetic alterations have been shown to contribute immensely to human carcinogenesis. Dynamic and reversible N6‐methyladenosine (m6A) RNA modification regulates gene expression and cell fate. However, the reasons for activation of KIAA1429 (also known as VIRMA, an RNA methyltransferase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Chang, Sun, Qi, Zhang, Xu, Qin, Na, Pu, Zhening, Gu, Yayun, Yan, Caiwang, Zhu, Meng, Dai, Juncheng, Wang, Cheng, Li, Ni, Jin, Guangfu, Ma, Hongxia, Hu, Zhibin, Zhang, Erbao, Tan, Fengwei, Shen, Hongbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257983/ https://www.ncbi.nlm.nih.gov/pubmed/35730068 http://dx.doi.org/10.1002/cac2.12325

Ejemplares similares

The biological function of m6A methyltransferase KIAA1429 and its role in human disease
por: Zhang, Xiaoyu, et al.
Publicado: (2022)

N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression
por: Gan, Lijuan, et al.
Publicado: (2023)

N(6)-methyladenosine methyltransferase KIAA1429 elevates colorectal cancer aerobic glycolysis via HK2-dependent manner
por: Li, Ying, et al.
Publicado: (2022)

m(6)A methyltransferase KIAA1429 accelerates oral squamous cell carcinoma via regulating glycolysis and ferroptosis
por: Xu, Ke, et al.
Publicado: (2023)

The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma
por: Luo, Jiaquan, et al.
Publicado: (2023)

N(6)-methyladenosine (m(6)A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer
por: Tang, Jun, et al.
Publicado: (2021)

KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma
por: Liu, Zhao-chen, et al.
Publicado: (2022)

KIAA1429 promotes infantile hemangioma regression by facilitating the stemness of hemangioma endothelial cells
por: Wang, Luying, et al.
Publicado: (2023)

m(6)A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA
por: Zhu, Zhongcheng, et al.
Publicado: (2022)

Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
por: Ma, Chao, et al.
Publicado: (2023)

m(6)A methyltransferase KIAA1429 acts as an oncogenic factor in colorectal cancer by regulating SIRT1 in an m(6)A-dependent manner
por: Zhou, Yuan, et al.
Publicado: (2022)

m6A ‘writer’ KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis
por: Rong, Jian, et al.
Publicado: (2022)

CRISPR-Cas9 knockout screening identifies KIAA1429 as an essential gene in Ewing sarcoma
por: Tan, Kezhe, et al.
Publicado: (2023)

KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN
por: Meng, Yu, et al.
Publicado: (2023)

A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer
por: Zhang, Xu, et al.
Publicado: (2022)

SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer
por: Zhang, Xu, et al.
Publicado: (2021)

KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA
por: Cheng, Xiaoyu, et al.
Publicado: (2019)

KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3
por: Lan, Tian, et al.
Publicado: (2019)

KIAA1429/VIRMA promotes breast cancer progression by m(6)A‐dependent cytosolic HAS2 stabilization
por: Li, Na, et al.
Publicado: (2023)

KIAA1429 mediates epithelial mesenchymal transition in sorafenib‐resistant hepatocellular carcinoma through m6A methylation modification
por: Kuang, Ye, et al.
Publicado: (2022)

N6-methyladenine- induced LINC00667 promoted breast cancer progression through m6A/KIAA1429 positive feedback loop
por: Ren, Saiyu, et al.
Publicado: (2022)

A functional variant in miR-155 regulation region contributes to lung cancer risk and survival
por: Xie, Kaipeng, et al.
Publicado: (2015)

Genetic Variation in the 3'-Untranslated Region of NBN Gene Is Associated with Gastric Cancer Risk in a Chinese Population
por: Sun, Ping, et al.
Publicado: (2015)

Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis
por: Li, Juncai, et al.
Publicado: (2023)

Genetic Variants in the Promoter Region of miR-10b and the Risk of Breast Cancer
por: Chen, Jiaping, et al.
Publicado: (2017)

The m(6)A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
por: Yao, Fangyi, et al.
Publicado: (2023)

KIAA1429-mediated m6A modification of CHST11 promotes progression of diffuse large B-cell lymphoma by regulating Hippo–YAP pathway
por: Chen, Xiaomin, et al.
Publicado: (2023)

KIAA1429 and ALKBH5 Oppositely Influence Aortic Dissection Progression via Regulating the Maturation of Pri-miR-143-3p in an m6A-Dependent Manner
por: Wang, Peng, et al.
Publicado: (2021)

Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022)

Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population
por: Lin, Xiaoming, et al.
Publicado: (2017)

DNA methyltransferases and their roles in tumorigenesis
por: Zhang, Wu, et al.
Publicado: (2017)

Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
por: Rodriguez-Paredes, M, et al.
Publicado: (2014)

Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype
por: Qin, Na, et al.
Publicado: (2020)

Tumor suppressors BTG1 and BTG2: Beyond growth control
por: Yuniati, Laurensia, et al.
Publicado: (2018)

Telomere length, genetic variants and risk of squamous cell carcinoma of the head and neck in Southeast Chinese
por: Gu, Yayun, et al.
Publicado: (2016)

SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling
por: Lv, Xiufang, et al.
Publicado: (2020)

Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
por: Wang, Anqi, et al.
Publicado: (2020)

Polygenic score: An anchor holding the whole life course
por: Jin, Guangfu, et al.
Publicado: (2023)

Systematic identification of long non-coding RNAs with cancer-testis expression patterns in 14 cancer types
por: Qin, Na, et al.
Publicado: (2017)

A novel plasma circular RNA circFARSA is a potential biomarker for non‐small cell lung cancer
por: Hang, Dong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_oe3bvhf74d65c726hehd10pcvg